Related Experiment Videos
[Prevention and treatment during the postmenopausal period]
1Katedry Endokrynologii i Plodności Collegium Medicum Uniwersytetu Jagiellońsklego w Krakowie.
Przeglad Lekarski
|January 1, 1997
Summary
Early diagnosis and prophylactic hormonal prevention are crucial for managing osteoporosis, especially during menopause and after age 35. Physiological doses offer effective treatment with minimal side effects.
Area of Science:
- Endocrinology
- Gynecology
- Gerontology
Context:
- Osteoporosis diagnosis and treatment are often influenced by prevailing medical trends rather than scientific evidence.
- The intensification of osteoporosis during menopause and related conditions necessitates timely intervention.
Purpose:
- To highlight the importance of early diagnosis and prophylactic hormonal prevention for osteoporosis.
- To advocate for a shift from belated substitutive treatment to early preventive strategies.
Summary:
- Specific conditions such as menopause, climacteric syndrome, anovulatory cycles after 35, pregnancy complications, puerperium infections, infertility, and prolonged oral contraceptive use are indicators for osteoporosis screening.
- Initiating prophylactic hormonal prevention before age 35 can preemptively manage postmenopausal disorders.
- Physiological doses of hormones are recommended for treatment to support natural sources and avoid post-pharmacological side effects like abnormal bleeding.
Impact:
- Promotes a proactive approach to osteoporosis management, emphasizing prevention over treatment.
- Encourages personalized postmenopausal hormonal therapy based on individual response and physician guidance.
- Aims to improve long-term bone health and reduce the incidence of osteoporosis-related complications.